Solvent-preserved, bovine cancellous bone blocks used for reconstruction of thoracolumbar fractures in minimally invasive spinal surgery-first clinical results

European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
Markus SchultheissErich Hartwig

Abstract

We investigated the osseointegration of solvent-preserved, xenogenous cancellous bone blocks in the treatment of unstable fractures of the thoracolumbar junction. In 22 patients, the anterior repair procedure was performed by thoracoscopy or minimally invasive retroperitoneal surgery. Twenty-two patients had undergone monosegmental anterior fusion and were surveyed prospectively. Solvent-preserved, bovine cancellous bone blocks were used in 11 patients; iliac crest bone graft was used in the others. Follow-up after 12 months included CT scans, which revealed successful osseointegration in eight out of 11 patients who had received autogenous iliac crest bone grafts, while three patients showed a partial integration. There were no graft fragmentations. In patients who had received solvent-preserved, xenogenous cancellous bone blocks, complete osseointegration was achieved at the graft-bone interface in only two out of 11 cases, after 1 year. Partial integration was found in three patients. In view of these results, autogenous iliac crest bone grafts are still the unrivalled standard for defect repair in spinal surgery.

References

Jan 1, 1994·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·F MagerlS Nazarian
Jan 23, 1998·Journal of Spinal Disorders·M KifuneT Oxland
Mar 28, 1998·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·V BührenM Potulski
Sep 3, 1999·The Orthopedic Clinics of North America·H S SandhuH Parvataneni
Feb 9, 2000·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·H L Defino, A E Rodriguez-Fuentes
Sep 30, 2000·Journal of Neurosurgery·P W HitchonK Totoribe
Jul 26, 2003·Clinical Biomechanics·Markus SchultheissHans-Joachim Wilke
Aug 5, 2003·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Markus SchultheissErich Hartwig

❮ Previous
Next ❯

Citations

Mar 28, 2008·International Orthopaedics·M R BansalD D Shukla
May 16, 2006·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Uta LangeMichael Blauth
Apr 10, 2009·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Christian KnopM Blauth
Mar 31, 2011·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Florian GeigerMichael Rauschmann
Oct 1, 2007·Indian Journal of Orthopaedics·Helton L A DefinoCarlos Few Romeiro
Jun 30, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Shayan FakurnejadZachary A Smith
Dec 3, 2014·Clinics in Podiatric Medicine and Surgery·Naohiro Shibuya, Daniel C Jupiter
May 28, 2011·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·Sunit PatilAndrew Gower

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.